Gujarat Themis Biosyn Limited (GUJTHEM) — Insider Trading
Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares at Rs. 382 per share (total value up to Rs. 20 crores) from Pharmaceutical Business Group (India) Limited, representing up to 0.50% of the company's share capital. The transaction is an inter-se transfer among promoters and is exempt from open offer under SEBI SAST Regulation 10(1)(a)(ii). The filing withdraws a prior disclosure made on 1 July 2026 due to missed deadlines, and confirms compliance with all regulatory requirements including price limits and disclosure norms.
About Gujarat Themis Biosyn Limited (GUJTHEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when GUJTHEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GUJTHEM — Free💡 Ask AI about this filing
📊 More GUJTHEM filings
- regulation 31 — 14 July 2026 Pharmaceutical Business Group (India) Limited disclosed an indirect encumbrance on its 47.02% stake ...
- Announcement — 13 July 2026 Gujarat Themis Biosyn Limited disclosed that it has amicably settled a commercial arbitration disput...
- 🟡 Voting Results — 10 July 2026 Gujarat Themis Biosyn Limited announced voting results for special resolutions passed via e-voting o...
- share transfer — 10 July 2026 Gujarat Themis Biosyn Limited received a SEBI-mandated certificate from MUFG Intime India confirming...
- 🔴 Insider Trading — 2 July 2026 Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares...
🔥 Also filed on 15 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when GUJTHEM files new disclosures
Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GUJTHEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research